Market Research Industry Reports

Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company, with focus on the research, development, production and distribution of patented Chinese medicines, chemical drugs and biological products. It offers products for the treatment of medical conditions related to central nervous system, digestive system, ophthalmic system, diabetic nephropathy, gastrointestinal, and others. The companys product portfolio includes Chinese medicines for the treatment of hypertension and hyperlipidemia, aripiprazole for anti-psychotic treatment and venlafaxine hydrochloride sustained release tablets for the treatment of depression. Its products are available in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification drugs and antiviral medicines, among others. The company distributes its products across China. Chengdu Kanghong Pharmaceuticals is headquartered in Chengdu, Sichuan, China.

Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Chengdu Kanghong Enters into Agreement with INC Research 10
Equity Offering 11
Chengdu Kanghong Pharma Raises USD101.2 Million in IPO 11
Acquisition 13
Chengdu Kanghong Pharma Plans to Acquire 7% Stake in Chengdu Based Pharma Unit for USD11 Million 13
Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 14
Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 15
Chengdu Kanghong Pharmaceuticals Group Co Ltd - Key Competitors 16
Chengdu Kanghong Pharmaceuticals Group Co Ltd - Key Employees 17
Chengdu Kanghong Pharmaceuticals Group Co Ltd - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chengdu Kanghong Enters into Agreement with INC Research 10
Chengdu Kanghong Pharma Raises USD101.2 Million in IPO 11
Chengdu Kanghong Pharma Plans to Acquire 7% Stake in Chengdu Based Pharma Unit for USD11 Million 13
Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 14
Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 15
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Key Competitors 16
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Key Employees 17
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Subsidiaries 18
Chengdu Kanghong Pharmaceuticals Group Co Ltd, Joint Venture 18

List Of Figures

List of Figures
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Chengdu Xuguang Electronics Co Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Chengdu Xuguang Electronics Co Ltd Company Profile is a detailed strategic and analytical report on Chengdu Xuguang Electronics Co Ltd. The 2018 version of the report offers detailed insights into

USD 200View Report

CHENGDU XUGUANG ELECTRONICS CO,.LTD Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

CHENGDU XUGUANG ELECTRONICS CO,.LTD Company Profile is a detailed strategic and analytical report on CHENGDU XUGUANG ELECTRONICS CO,.LTD. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Chengdu Kanghong Pharmaceuticals Group Co Ltd (00277) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company, which concentrates on the research, development, production and distribution of patented Chinese medicines, chemical drugs and biological

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :19
Country :China
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube